These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11083547)

  • 1. Simplified quantitative determination of cerebral perfusion reserve with H2(15)O PET and acetazolamide.
    Arigoni M; Kneifel S; Fandino J; Khan N; Burger C; Buck A
    Eur J Nucl Med; 2000 Oct; 27(10):1557-63. PubMed ID: 11083547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate.
    Treyer V; Jobin M; Burger C; Teneggi V; Buck A
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):572-80. PubMed ID: 12552334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
    Ogasawara K; Ito H; Sasoh M; Okuguchi T; Kobayashi M; Yukawa H; Terasaki K; Ogawa A
    J Nucl Med; 2003 Apr; 44(4):520-5. PubMed ID: 12679394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography.
    Carroll TJ; Teneggi V; Jobin M; Squassante L; Treyer V; Hany TF; Burger C; Wang L; Bye A; Von Schulthess GK; Buck A
    J Cereb Blood Flow Metab; 2002 Sep; 22(9):1149-56. PubMed ID: 12218421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography.
    Gambhir S; Inao S; Tadokoro M; Nishino M; Ito K; Ishigaki T; Kuchiwaki H; Yoshida J
    Neurol Res; 1997 Apr; 19(2):139-44. PubMed ID: 9175142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional cerebral blood flow measurements at pre- and post-Diamox test using split dose 99mTc-ECD SPECT: comparison with 133Xe inhalation method and linearization correction].
    Sogabe I
    Kaku Igaku; 1997 Jan; 34(1):35-44. PubMed ID: 9059012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of ¹²³I-IMP arterial blood activity using ¹²³I-IMP acquisition data from the lungs and brain without any blood sampling: validation of its usefulness for quantification of regional cerebral blood flow.
    Abe S; Kato K; Takahashi Y; Fujita N; Yamashita M; Shinoda M; Ikeda M; Ohta N; Kajita Y; Naganawa S
    Clin Nucl Med; 2012 Mar; 37(3):258-63. PubMed ID: 22310252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B; Westera G; Treyer V; Burger C; Khan N; Buck A
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoreactive effect of acetazolamide as a function of time with sequential PET 15O-water measurement.
    Hayashida K; Tanaka Y; Hirose Y; Kume N; Iwama T; Miyake Y; Ishida Y; Matsuura H; Miyake Y; Nishimura T
    Nucl Med Commun; 1996 Dec; 17(12):1047-51. PubMed ID: 9004301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET.
    Yokoi T; Iida H; Itoh H; Kanno I
    J Nucl Med; 1993 Mar; 34(3):498-505. PubMed ID: 8441045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Perfusion Imaging Under Acetazolamide Challenge for Detection of Impaired Cerebrovascular Reserve Capacity: Positive Findings with
    Acker G; Lange C; Schatka I; Pfeifer A; Czabanka MA; Vajkoczy P; Buchert R
    J Nucl Med; 2018 Feb; 59(2):294-298. PubMed ID: 28729429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of the cerebrovascular responses to CO2 and Diamox in patients with unilateral occlusive cerebral arteries: a H2(15)O PET study].
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1995 Jun; 32(6):569-77. PubMed ID: 7674567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Masuda K
    Stroke; 1995 Oct; 26(10):1825-9. PubMed ID: 7570733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion-CT assessment of the cerebrovascular reserve: a revisit to the acetazolamide challenges.
    Smith LM; Elkins JS; Dillon WP; Schaeffer S; Wintermark M
    J Neuroradiol; 2008 Jul; 35(3):157-64. PubMed ID: 18242708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: II. Normal values and gray matter blood flow response to visual activation.
    Law I; Iida H; Holm S; Nour S; Rostrup E; Svarer C; Paulson OB
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1252-63. PubMed ID: 10950384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.